Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Altimmune, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC

May 15, 2026 4:22 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Tang Capital Management, LLC ("TCM") shares voting and dispositive power over such shares with Tang Capital Partners International, LP ("TCPI") and Kevin Tang. The percentages used herein are based on 194,199,358 shares of Common Stock outstanding as of April 24, 2026, as set forth in the Prospectus filed on Form 424B5 that was filed with the Securities and Exchange Commission on April 24, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Kevin Tang shares voting and dispositive power over such shares with TCPI and TCM.


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: TCPI shares voting and dispositive power over such shares with TCM and Kevin Tang.


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



TANG CAPITAL MANAGEMENT, LLC
Signature:/s/ Kevin Tang
Name/Title:Manager
Date:05/15/2026
KEVIN TANG
Signature:/s/ Kevin Tang
Name/Title:Self
Date:05/15/2026
TANG CAPITAL PARTNERS, LP
Signature:/s/ Kevin Tang
Name/Title:Manager, Tang Capital Management, LLC, General Partner
Date:05/15/2026
TANG CAPITAL PARTNERS INTERNATIONAL, LP
Signature:/s/ Kevin Tang
Name/Title:Manager, Tang Capital Management, LLC, General Partner
Date:05/15/2026
TANG CAPITAL PARTNERS III, INC
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:05/15/2026
TANG CAPITAL PARTNERS IV, INC
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:05/15/2026

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

Categories

SEC Filings